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Background: Kaposi's sarcoma (KS) is an uncommon borderline vascular tumor involving mostly the cutaneous and
mucosal sites of the body. Among the four distinctly clinicopathological presentations of KS, the iatrogenic form
principally occurs in kidney transplant recipients receiving immunosuppressive therapy. It rarely occurs in the head
and neck region as primary site or in other groups of patients under immunosuppressive therapy.
Case presentation: We present of the case of a patient with right nose KS. The patient had history of systemic
lupus erythematosus (SLE) and was under immunosuppressive therapy.
Conclusion: Once we keep KS in mind, the definite diagnosis can be made using routine histological examination
and immunohistochemical study despite the rarity of the disease in this site.
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Kaposi's sarcoma (KS) was named after an Austrian
dermatologist, Moritz Kaposi, who first described five
cases of this unusual tumor in 1872 [1]. KS is primarily
a borderline vascular tumor affecting the skin and mu-
cosa, but in more advanced stages of the disease, the
lymph nodes and almost any internal organ can also be
involved. There are four distinctly clinicopathological
presentations: the ‘classic’ or ‘sporadic’ form mostly oc-
curring in the lower extremities in elderly patients with
Mediterranean or Jewish ancestry, the rapidly progres-
sive ‘epidemic’ form associated with the acquired im-
munodeficiency syndrome (AIDS), the ‘endemic’ form
prevalent in middle-aged adults and children from
sub-Saharan Africa, and the ‘iatrogenic’ form, which is
associated with immunosuppressive therapies for organ
transplants or other illnesses. Nonetheless, the histo-
logical features of all forms of KS are essentially the
same, and human herpesvirus 8 (HHV8) is considered
the causative agent for all forms of KS. Tumor develop-
ment requires prior infection with HHV8 but HHV8
infection alone is not sufficient to induce it. Here, we
present a patient with systemic lupus erythematosus* Correspondence: r22068@cgmh.org.tw
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unless otherwise stated.(SLE) and an immunosuppressed state suffering from
iatrogenic KS in the nose, a rarely primary site of KS.
Case presentation
A 31-year-old woman presented with a 1-month history
of swelling on the right side of her nose. She also had a
history of SLE with lupus nephritis and was under
immunosuppressive therapy, mainly with prednisolone
ranging from 10 to 20 mg per day for 9 years. A physical
examination revealed no other specific findings. A sino-
scopic examination showed a bulging nodule on her
right anterior nasal floor near the nostril. Folliculitis
with secondary infection was initially diagnosed, and
amoxicillin with clavulanic acid was prescribed, but the
lesion remained despite 1-week of the medication. A bi-
opsy was undertaken for the suspicion of neoplasm.
The specimen received consisted of five fragments of
tissue measuring up to 0.5 × 0.4 × 0.1 cm with a soft
consistency and focal hemorrhage. Histological analyses
under hematoxylin and eosin (H & E) staining revealed a
submucosal nodular tumor effacing normal structures
(Figure 1). The tumor was composed of intersecting ill-
defined fascicles of plump, spindled tumor cells with mild
to moderate nuclear atypia. Mitoses were easily found.
The tumor cells formed slit- and sieve-like vascular spaces
containing erythrocytes (Figure 2A). Eosinophilic hyaline
globules were seen in some tumor cells (Figure 2B).td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Histopathology (40×, H & E staining). Histological
examination showed a polypoid submucosal tumor effacing
normal structures.
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sels were seen at the periphery of the tumor. Immunohis-
tochemical (IHC) stains revealed that the tumor cells were
strongly positive for CD31, CD34, D2-40, and latency-
associated nuclear antigen (LANA-1) (Figure 3). Desmin,
S-100, and AE1/AE3 immunostains were performed and
the results were negative. Serological tests for human im-
munodeficiency virus antigen/antibody were negative. The
final pathology diagnosis was iatrogenic Kaposi's sarcoma.
Discussion
Iatrogenic KS principally occurs in kidney transplant re-
cipients receiving immunosuppressive therapy. The inci-
dence varies among different patient groups, but there is
a 500- to 1000-fold difference compared to the general
population [2]. The disease develops an average of 10 to
22 months after transplantation in this setting. The sec-
ond group of patients at risk are those who received
immunosuppressive therapy for a variety of medical rea-
sons such as some hematological disorders, asthma,Figure 2 Histopathology (400×, H & E staining). (A) There are slit- and
erythrocytes. (B) Some eosinophilic hyaline globules were seen in tumor ceulcerative colitis, or rheumatic diseases (such as SLE, as
in our patient) [3]. In this group, KS develops around 41
months after the initiation of immunosuppressant ther-
apy, and the incidence rate is 2- to 4-fold lower com-
pared to renal transplant patients. The exact mechanism
of KS associated with iatrogenic immunosuppression is
unknown, but reactivation of the pre-existing HHV8 in-
fection is thought to be the cause. Reactivation of the
virus and the development of the KS are influenced by
multiple factors including sex hormones, age, genetics,
immune status, and cytokines [4]. Immunosuppression
caused by steroid or other cytotoxic drugs could weaken
the immunological surveillance mechanism. Additionally,
some studies have shown that corticosteroids play a direct
role in the development of Kaposi’s sarcoma, either by up-
regulating KS cell proliferation or by reactivating the pre-
existing HHV8 [5,6].
However, most patients receiving corticosteroids or
other immunosuppressive regimens do not develop KS,
especially in non-transplant settings. Although it has
been stated that Kaposi's sarcoma also has a higher inci-
dence in patients who have received immunosuppression
therapy for various medical diseases, Louthrenoo et al.
had found that only 24 documented rheumatologic pa-
tients from 1966 to 2002 developed KS [4]. Considering
the worldwide extensive use of corticosteroids and/or
other immunosuppressive drugs in patients with rheum-
atic disease, KS appears to be an extremely rare compli-
cation. There were only four cases of SLE complicated
by KS documented in the English literature [4,7]. This
finding supports the concept that the development of KS
may require additional ethnic, genetic, or environmental
predisposing factors other than immunosuppression alone.
The rarity of this phenomenon could even raise the suspi-
cion of a causal relationship between immunosuppression
and the development of KS in these individuals. However,
the regression of KS occurred in many of these patients
after discontinuing or decreasing the dosage of immuno-
suppressive drugs, implying that the immunosuppressedsieve-like vascular spaces formed by tumor cells with abundant
lls.
Figure 3 Immunohistochemical stains. The tumor cells were positive for CD31 (A, 200×), CD34 (B, 200×), and D2-40 (C, 200×) with nuclear stain
for the latency-associated nuclear antigen (LANA-1) antibody (D, 400×). The diagnosis was confirmed.
Chen et al. World Journal of Surgical Oncology 2014, 12:172 Page 3 of 4
http://www.wjso.com/content/12/1/172state caused by these medications plays at least some role
in the development of iatrogenic KS [4].
Although KS is well known to occur at almost any cu-
taneous and mucosal site of the body, the head and neck
region is usually secondarily involved and rarely the site
of initial presentation [8]. KS primarily involving the
nasal mucosa is exceedingly rare, with only seven cases
reported previously in the English literature; only two of
them were not AIDS-associated presentations [9,10].
The nasal cavity is an infrequent location of primary
malignant neoplasms. Approximately 1% of all human
malignancies occur at this site, and more than 99% of
these are squamous cell carcinoma [9]. The rarity of the
otherwise not infrequently encountered Kaposi’s sar-
coma in this location can become a pitfall in diagnosis.
Clinically or pathologically, several diagnoses including
lobular capillary hemangioma, spindle-cell hemangioen-
dothelioma, spindle-cell angiosarcoma, glomangioperi-
cytoma, bacillary angiomatosis, spindle-cell squamous
cell carcinoma, and even synovial sarcoma could enter
the differential list. However, if one keeps in mind the
possibility of the existence of this tumor, it is often not
difficult to establish or at least suspect the diagnosis of
KS under routine H & E histological examination. The key
point of correct diagnosis is in identifying the vessel-
forming property of the tumor cells, the slit- and sieve-like
vascular spaces, the spindle cells with relatively monoton-
ous and low-grade nuclei, and the eosinophilic hyalinegranules found in the cytoplasm. Additionally, CD31
(a pan-endothelial cell marker) and D2-40 (a lymphatic
endothelial cell marker) are strongly expressed in both
the spindle- and endothelial-cell components of Kapo-
si’s sarcoma. Finally, identifying the nuclear staining by
immunohistochemical methods using the LANA-1 anti-
body essentially confirms the diagnosis.
The behavior and thus the treatment of KS depend
on a number of factors such as the form of the dis-
ease, symptoms, location and extent of the lesion, the
immunocompetence of the patient, and the general
medical condition of the patient [9]. Local excision, ra-
diation therapy, chemotherapy, and the adjustment of
immunosuppressive medications could all be consid-
ered. Local recurrence is common in AIDS-KS patients
but survival is more related to the immunological sta-
tus of these patients; the mortality rate can reach 20
to 25% [10]. In patients with iatrogenic KS associated
with immunosuppressants for rheumatic disease, tumor
regression occurred in response to treatment in about
two-thirds of cases [4]. Primary mucosal KS appears to
have a similar prognosis to that of the typical cutaneous
form presenting on the extremities [8]. Our patient had
undergone local excision and low-dose radiation ther-
apy (3000 cGy). The dosage of immunosuppressive
medication was not adjusted. There was no recurrence
during the four years of follow-up, prior to this case
presentation.
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KS is an uncommon borderline vascular tumor, which
occurs under various clinicopathological settings. KS is
rare in the head and neck region and primary develop-
ment in the nasal cavity is exceptional. Although iatro-
genic KS is not uncommonly encountered in renal
transplantation patients, it is rare in patients under im-
munosuppressive therapy for other medical reasons.
The diagnosis of KS requires a high level of suspicion
during histological examination and a panel of IHC
studies would generally produce a firm conclusion. The
treatment and prognosis depend on multiple factors and
require consideration on a case-by-case basis.
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